SARS-CoV-2 mRNA vaccines sensitize tumors to immune checkpoint blockade

被引：0
|
作者：
Grippin, Adam
Marconi, Christiano
Copling, Sage
Mendez-Gomez, Hector
Wargo, Jennifer
Heymach, John
Jiang, Wen
Sayour, Elias
Lin, Steven H.
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2025年 / 13卷 / 02期
关键词：
D O I：
10.1158/2326-6074.IO2025-B125
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B125
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The Immune Response to SARS-CoV-2: Mechanisms, Aging, Sequelae, and Vaccines
    Espinoza, Carolina
    Alarcon, Marcelo
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2022, 22 (16) : 2166 - 2185
  • [42] Divergent Immune Responses to SARS-CoV-2 Vaccines in Immunocompromised Patients
    Jordan, Stanley C.
    Shin, Bong-Ha
    Gadsden, Terry-Ann M.
    Chu, Maggie
    Petrosyan, Anna
    Vo, Ashley
    Ammerman, Noriko
    Sethi, Supreet
    Najjar, Reiad
    Huang, Ed
    Peng, Alice
    Toyoda, Mieko
    Kumar, Sanjeev
    Zhang, Ruan
    TRANSPLANTATION, 2022, 106 (01) : E90 - E91
  • [43] Development of SARS-CoV-2 vaccines
    Barajas-Nava, Leticia A.
    BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2021, 78 (01): : 66 - 74
  • [44] Nanocarrier vaccines for SARS-CoV-2
    Machhi, Jatin
    Shahjin, Farah
    Das, Srijanee
    Patel, Milankumar
    Abdelmoaty, Mai Mohamed
    Cohen, Jacob D.
    Singh, Preet Amol
    Baldi, Ashish
    Bajwa, Neha
    Kumar, Raj
    Vora, Lalit K.
    Patel, Tapan A.
    Oleynikov, Maxim D.
    Soni, Dhruvkumar
    Yeapuri, Pravin
    Mukadam, Insiya
    Chakraborty, Rajashree
    Saksena, Caroline G.
    Herskovitz, Jonathan
    Hasan, Mahmudul
    Oupicky, David
    Das, Suvarthi
    Donnelly, Ryan F.
    Hettie, Kenneth S.
    Chang, Linda
    Gendelman, Howard E.
    Kevadiya, Bhavesh D.
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 171 : 215 - 239
  • [45] SARS-CoV-2 and interferon blockade
    Diamond, Betty
    Volpe, Bruce T.
    VanPatten, Sonya
    Al Abed, Yousef
    MOLECULAR MEDICINE, 2020, 26 (01)
  • [46] SARS-CoV-2 and interferon blockade
    Betty Diamond
    Bruce T. Volpe
    Sonya VanPatten
    Yousef Al Abed
    Molecular Medicine, 2020, 26
  • [47] Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab
    Barbora Bacova
    Zuzana Kohutova
    Ivana Zubata
    Lubica Gaherova
    Petr Kucera
    Tomas Heizer
    Marcela Mikesova
    Tomas Karel
    Jan Novak
    Clinical and Experimental Medicine, 2023, 23 : 371 - 379
  • [48] SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naive and Pre-Immune Humans
    Forgacs, David
    Jang, Hyesun
    Abreu, Rodrigo B.
    Hanley, Hannah B.
    Gattiker, Jasper L.
    Jefferson, Alexandria M.
    Ross, Ted M.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [49] Tracking the immune response to SARS-CoV-2 mRNA vaccines in ofatumumab treated RMS patients in a multicenter study
    Ziemssen, T.
    Ettle, B.
    Groth, M.
    Bopp, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 151 - 151
  • [50] Monitoring of the immune response against SARS-CoV-2 in patients with common variable immunodeficiency vaccinated with mRNA vaccines
    Gutierrez-Bautista, Juan Francisco
    Fernandez Perea, Beatriz
    Ballesta Alcaraz, Lucia
    Barrera Aguilera, Maria del Carmen
    Bernal, Monica
    Marin, Ana
    Jimenez, Pilar
    Ramon Vilchez, Jose
    Angel Lopez-Nevot, Miguel
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1662 - 1662
12345